HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marco Giovannini Selected Research

Mesothelioma

2/2011Syntenic relationships between genomic profiles of fiber-induced murine and human malignant mesothelioma.
12/2005Similar tumor suppressor gene alteration profiles in asbestos-induced murine and human mesothelioma.
6/2003Hemizygosity of Nf2 is associated with increased susceptibility to asbestos-induced peritoneal tumours.
4/2003Quinidine impairs proliferation of neurofibromatosis type 2-deficient human malignant mesothelioma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marco Giovannini Research Topics

Disease

47Neoplasms (Cancer)
01/2022 - 10/2002
21Neurofibromatosis 2 (Neurofibromatosis Type II)
01/2022 - 08/2002
17Neurilemmoma (Schwannoma)
11/2019 - 08/2002
10Carcinogenesis
11/2016 - 06/2003
8Pain (Aches)
01/2016 - 01/2004
7Meningioma (Meningiomas)
06/2017 - 07/2007
6Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2018 - 05/2011
6Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2018 - 12/2013
6Neurofibromatoses (Neurofibromatosis)
01/2018 - 04/2003
5Schwannomatosis
01/2022 - 03/2013
5Neurofibromatosis 1 (Neurofibromatosis Type I)
01/2018 - 01/2004
4Neoplasm Metastasis (Metastasis)
11/2020 - 05/2003
4Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
09/2017 - 01/2014
4Acoustic Neuroma (Acoustic Neurinoma)
06/2017 - 06/2009
4Hematologic Neoplasms (Hematological Malignancy)
01/2016 - 10/2009
4Myelodysplastic Syndromes (Myelodysplastic Syndrome)
02/2015 - 07/2013
4Mesothelioma
02/2011 - 04/2003
3Glioma (Gliomas)
01/2018 - 07/2007
3Non-Hodgkin Lymphoma (Lymphosarcoma)
08/2013 - 06/2008
3Neurofibrosarcoma (MPNST)
01/2013 - 06/2009
3Renal Insufficiency (Renal Failure)
06/2012 - 06/2010
3Malignant Mesothelioma
02/2011 - 04/2003
3Mucositis
10/2009 - 08/2006
2Cancer Pain
01/2016 - 09/2011
2Hemolytic Anemia
05/2014 - 10/2008
2Autoimmune Hemolytic Anemia (Cold Agglutinin Disease)
07/2012 - 07/2009
2Chronic Kidney Failure (Chronic Renal Failure)
05/2011 - 05/2011
2Hemorrhage
01/2011 - 03/2009
2Thrombocytopenia (Thrombopenia)
01/2011 - 04/2009
2Multiple Myeloma
03/2010 - 04/2009
2Leukemia
02/2010 - 04/2009
2Stomatitis
10/2009 - 01/2004
2Nervous System Neoplasms (Neoplasms, Nervous System)
07/2007 - 08/2002
2Ascites
12/2005 - 06/2003
1Osteosarcoma (Osteogenic Sarcoma)
11/2020
1Legius syndrome
01/2018
1Inborn Genetic Diseases (Disease, Hereditary)
01/2018
1Musculoskeletal Abnormalities
01/2018
1Nerve Sheath Neoplasms (Nerve Sheath Neoplasm)
10/2017
1Neuroblastoma
06/2017
1Sarcoma (Soft Tissue Sarcoma)
06/2017
1Ulcer
01/2017
1Inflammation (Inflammations)
11/2016
1Hepatomegaly
11/2016
1Glucosephosphate Dehydrogenase Deficiency
03/2016
1Hearing Loss (Hearing Impairment)
01/2016

Drug/Important Bio-Agent (IBA)

27Neurofibromin 2 (Merlin)IBA
11/2020 - 08/2002
7Proteins (Proteins, Gene)FDA Link
11/2019 - 01/2007
7Analgesics (Analgesic Drugs)IBA
01/2016 - 01/2004
6Rituximab (Mabthera)FDA Link
03/2016 - 10/2008
4Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2019 - 05/2008
4Azacitidine (5 Azacytidine)FDA Link
09/2017 - 01/2014
4Opioid Analgesics (Opioids)IBA
01/2016 - 08/2006
3Uvitex SWN (SWN)IBA
01/2022 - 06/2017
3DecitabineFDA Link
01/2018 - 01/2017
3EverolimusFDA Link
10/2017 - 04/2015
3Biomarkers (Surrogate Marker)IBA
06/2017 - 10/2002
3eltrombopagFDA Link
03/2016 - 03/2014
3AsbestosIBA
02/2011 - 06/2003
2IntegrinsIBA
11/2020 - 08/2011
2Neurofibromin 1 (Neurofibromin)IBA
01/2018 - 01/2018
2Mechanistic Target of Rapamycin Complex 1IBA
04/2015 - 04/2014
2TOR Serine-Threonine KinasesIBA
04/2015 - 04/2014
2romiplostimFDA Link
10/2014 - 03/2014
2moesinIBA
12/2011 - 08/2011
2ezrinIBA
12/2011 - 08/2011
2radixinIBA
12/2011 - 08/2011
2Oxycodone (Oxycontin)FDA LinkGeneric
06/2010 - 09/2007
2Tumor Suppressor Protein p14ARF (p14ARF)IBA
01/2008 - 12/2005
2Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA
07/2007 - 01/2007
1Integrin alpha4beta1 (VLA-4)IBA
11/2020
1Messenger RNA (mRNA)IBA
11/2019
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
11/2019
1Caspase 9IBA
11/2019
1Staphylococcal Protein A (Protein A)IBA
11/2019
1Adenosine Triphosphate (ATP)IBA
11/2019
1Caspase 3 (Caspase-3)IBA
11/2019
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
01/2019
1trametinibIBA
01/2019
1DNA (Deoxyribonucleic Acid)IBA
01/2019
1Syk KinaseIBA
01/2018
1nilotinibFDA Link
10/2017
1Bevacizumab (Avastin)FDA Link
10/2017
1Lapatinib (GW572016)FDA Link
10/2017
1Hemoglobins (Hemoglobin)IBA
01/2017
1CyclinsIBA
11/2016
1CytokinesIBA
11/2016
1Reactive Oxygen Species (Oxygen Radicals)IBA
11/2016
1SteroidsIBA
03/2016

Therapy/Procedure

19Therapeutics
10/2017 - 10/2002
3Aftercare (After-Treatment)
10/2017 - 01/2006
3Radiotherapy
10/2017 - 09/2009
3Salvage Therapy
01/2017 - 06/2008
3Pain Management
06/2012 - 08/2006
2Palliative Care (Palliative Therapy)
01/2014 - 03/2009
2Drug Therapy (Chemotherapy)
03/2013 - 10/2009
2Hematopoietic Stem Cell Transplantation
01/2013 - 10/2009
2Transplantation
01/2013 - 01/2004
2Stem Cell Transplantation
03/2009 - 09/2007
1Intravenous Injections
11/2020